Indoor Biotechnologies, Basic Research, Charlottesville, VA, USA.
School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Mol Immunol. 2018 Aug;100:3-13. doi: 10.1016/j.molimm.2018.03.003. Epub 2018 Apr 4.
A systematic nomenclature for allergens originated in the early 1980s, when few protein allergens had been described. A group of scientists led by Dr. David G. Marsh developed a nomenclature based on the Linnaean taxonomy, and further established the World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-Committee in 1986. Its stated aim was to standardize the names given to the antigens (allergens) that caused IgE-mediated allergies in humans. The Sub-Committee first published a revised list of allergen names in 1986, which continued to grow with rare publications until 1994. Between 1994 and 2007 the database was a text table online, then converted to a more readily updated website. The allergen list became the Allergen Nomenclature database (www.allergen.org), which currently includes approximately 880 proteins from a wide variety of sources. The Sub-Committee includes experts on clinical and molecular allergology. They review submissions of allergen candidates, using evidence-based criteria developed by the Sub-Committee. The review process assesses the biochemical analysis and the proof of allergenicity submitted, and aims to assign allergen names prior to publication. The Sub-Committee maintains and revises the database, and addresses continuous challenges as new "omics" technologies provide increasing data about potential new allergens. Most journals publishing information on new allergens require an official allergen name, which involves submission of confidential data to the WHO/IUIS Allergen Nomenclature Sub-Committee, sufficient to demonstrate binding of IgE from allergic subjects to the purified protein.
过敏原的系统命名法起源于 20 世纪 80 年代早期,当时只有少数蛋白质过敏原被描述过。由 David G. Marsh 博士领导的一组科学家基于林奈分类法制定了一种命名法,并于 1986 年进一步成立了世界卫生组织/国际免疫学会联合会(WHO/IUIS)过敏原命名小组委员会。其明确目标是标准化引起人类 IgE 介导过敏的抗原(过敏原)的名称。该小组委员会于 1986 年首次发布了修订后的过敏原名称列表,该列表随着罕见出版物的发表而不断增加,直到 1994 年。1994 年至 2007 年,该数据库是一个在线文本表,然后转换为更易于更新的网站。过敏原列表成为过敏原命名数据库(www.allergen.org),其中目前包含来自各种来源的大约 880 种蛋白质。小组委员会包括临床和分子变态反应学方面的专家。他们使用小组委员会制定的基于证据的标准审查过敏原候选物的提交。审查过程评估提交的生化分析和变应原性证据,并旨在在发表之前分配过敏原名称。小组委员会维护和修订数据库,并应对新的“组学”技术提供有关潜在新过敏原的越来越多的数据所带来的持续挑战。发表有关新过敏原信息的大多数期刊都要求使用官方的过敏原名称,这涉及向 WHO/IUIS 过敏原命名小组委员会提交机密数据,足以证明过敏患者的 IgE 与纯化蛋白结合。